|
SPRED1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.989500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.506300E-02 |
| Normal-vs-Stage2 |
4.197400E-01 |
| Normal-vs-Stage3 |
1.495150E-01 |
| Normal-vs-Stage4 |
8.415200E-01 |
| Stage1-vs-Stage2 |
6.502600E-01 |
| Stage1-vs-Stage3 |
7.180000E-01 |
| Stage1-vs-Stage4 |
3.801600E-01 |
| Stage2-vs-Stage3 |
8.457400E-01 |
| Stage2-vs-Stage4 |
6.616000E-01 |
| Stage3-vs-Stage4 |
4.271800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.140300E-02 |
| Normal-vs-AfricanAmerican |
1.673420E-01 |
| Normal-vs-Asian |
1.528790E-01 |
| Caucasian-vs-AfricanAmerican |
7.550200E-01 |
| Caucasian-vs-Asian |
6.914800E-01 |
| AfricanAmerican-vs-Asian |
6.483200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.048310E-02 |
| Normal-vs-Female |
8.517800E-01 |
| Male-vs-Female |
3.156700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.580580E-01 |
| Normal-vs-Extreme_Weight |
4.788100E-02 |
| Normal-vs-Obese |
2.838600E-01 |
| Normal-vs-Extreme_Obese |
3.440300E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.117600E-01 |
| Normal_Weight-vs-Obese |
6.845800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.089830E-01 |
| Extreme_Weight-vs-Obese |
3.976200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.656000E-02 |
| Obese-vs-Extreme_Obese |
1.165910E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.576000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.184000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.722140E-02 |
| Normal-vs-Age(81-100Yrs) |
3.596000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.067700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.092140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.787800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.178600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.232450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.954300E-02 |
| Normal-VS-Type2 PRCC |
3.799900E-03 |
| Normal-VS-KIRP CIMP |
3.793800E-01 |
| Normal-VS-Unclassified PRCC |
4.174200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.752800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.698400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.088200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.677300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.813960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.423400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.434100E-04 |
| Normal-vs-N1 |
4.995200E-01 |
| Normal-vs-N2 |
5.526200E-01 |
| N0-vs-N1 |
2.782300E-02 |
| N0-vs-N2 |
2.060200E-02 |
| N1-vs-N2 |
3.997200E-01 |
|
|
